Identification of a Novel Chemokine-related Long Non-coding RNA Risk Model Via Comprehensive Prognostic and Immune Analyses in Pancreatic Cancer | Synapse
April 19, 2026
Identification of a Novel Chemokine-related Long Non-coding RNA Risk Model Via Comprehensive Prognostic and Immune Analyses in Pancreatic Cancer
Key Points
To establish a chemokine-related long non-coding RNA risk model and evaluate its prognostic significance in pancreatic cancer.
Conducted comprehensive analyses of chemokine-related lncRNAs
Evaluated the prognostic value of the identified model
Performed immune analyses related to the risk model
The lncRNA risk model showed significant prognostic value in pancreatic cancer
Potential implications for developing new therapeutic strategies were identified
Abstract
The chemokine-related lncRNAs risk model established in this study exhibits significant prognostic value in PC and may provide new insights for future therapeutic strategies.